ReShape Lifesciences Inc. Share Price
Equities
RSLS
US76090R2004
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.167 USD | +0.60% | -0.65% | -33.12% |
12/04 | North American Morning Briefing : Big Banks Kick -2- | DJ |
01/04 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
Sales 2024 * | 9.99M 834M | Sales 2025 * | 11.99M 1B | Capitalization | 3.92M 327M |
---|---|---|---|---|---|
Net income 2024 * | -6M -500M | Net income 2025 * | -5M -417M | EV / Sales 2024 * | 0.39 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-0.46
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on ReShape Lifesciences Inc.
1 day | +0.60% | ||
1 week | -0.65% | ||
Current month | +0.60% | ||
1 month | +2.71% | ||
3 months | -19.71% | ||
6 months | -35.10% | ||
Current year | -33.12% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01/20/01 |
Director of Finance/CFO | 63 | 15/21/15 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01/16/01 |
Dan Gladney
CHM | Chairman | 70 | 01/15/01 |
Director/Board Member | 70 | 15/21/15 |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 0.167 | +0.60% | 201,123 |
30/24/30 | 0.166 | +2.34% | 93,613 |
29/24/29 | 0.1622 | -4.48% | 282,554 |
26/24/26 | 0.1698 | -4.61% | 318,579 |
25/24/25 | 0.178 | +5.89% | 176,187 |
Delayed Quote Nasdaq, May 02, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.12% | 3.92M | |
+8.33% | 219B | |
+6.72% | 183B | |
+10.18% | 132B | |
+24.91% | 106B | |
-2.02% | 62.09B | |
+10.56% | 50.8B | |
+4.81% | 50.88B | |
-0.24% | 40.64B | |
+1.22% | 35.71B |
- Stock Market
- Equities
- RSLS Stock